Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
Clinical trial NCT00725231 · UNKNOWN
Trial details
- NCT number
- NCT00725231
- Sponsor
- University of Göttingen
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.